Back
ESC2025 Premium Access

Pre-existing cardiovascular disease does not augment the post-acute sequalae of SARS-CoV-2.

Session: Secondary prevention of cardiovascular disease
Topic: Secondary Prevention
Speaker: Mr J. Smith (Melbourne, AU)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Joel Smith

Baker Heart and Diabetes Institute, Melbourne (Australia)
0 follower

4 more presentations in this session

An innovative multi-disciplinary cardiometabolic clinic for patients with atherosclerotic cardiovascular disease leads to improved risk factor optimisation compared to standard care

Speaker: Doctor H. Evans (Gateshead, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Mediterranean lifestyle for secondary prevention of cardiovascular disease: the MEDLIFE pilot study

Speaker: Doctor J. Diaz-Gutierrez (Huelva, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

In-hospital influenza and COVID-19 vaccine availability during acute coronary syndrome boosts vaccination rates and improves outcomes versus out-of-season patients advised post-discharge vaccination

Speaker: Doctor A. Meseguer Hernandez (Cartagena, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Early predictors of progression of short paroxysmal atrial fibrillation

Speaker: Associate Professor T. Danilevich (Vinnytsa, UA)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Secondary prevention of cardiovascular disease

Speakers: Mr J. Smith, Doctor H. Evans, Doctor J. Diaz-Gutierrez, Doctor A. Meseguer Hernandez, Associate Professor T. Danilevich
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources